Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Medicine UCSF Medical Center
Home

Main navigation

  • About
    • Leadership
    • Faculty Profiles
    • Staff
    • Locations
    • History
  • Education
    • Fellowship Programs
      • ACGME Gastroenterology Fellowship
        • Mission Statement
        • Rotation Activities
        • Teaching
        • Coaching Program
        • ACGME GI Fellowship: How to Apply
        • Continuing Medical Education
        • Quality & Safety
          • News
          • Didactics and Academic Year
          • Projects
          • Resources
      • ACGME Transplant Hepatology Fellowship
        • ACGME Transplant Hepatology Fellowship: How to Apply
        • Transplant Hepatology Former Fellows
      • Non-ACGME Acute and Chronic Liver Disease Fellowship
      • Inflammatory Bowel Disease Fellowship
        • IBD Fellows
        • IBD Fellowship: How to Apply
      • Advanced Endoscopy Fellowship
    • Current Fellows
  • Patient Care
    • Clinical Services & Physician Contact
  • Research
    • Research in Gastrointestinal Disease
    • Research in Liver Disease
    • Research by Current Faculty
    • PIANO
      • How to Enroll
      • About Dr. Uma Mahadevan
      • Research and Resources
      • Donate
    • Gastroenterology Utilization of Tissue (GUT) Committee
  • Lynch Syndrome Center
  • Colitis & Crohns Center
    • Faculty & Providers
    • Clinical Trials
      • PIANO
    • Inflammatory Bowel Disease Fellowship
    • Updates in Inflammatory Bowel Disease National Symposium
    • Digital Resources for Patients
    • UCSF IBD Townhalls
    • UCSF Setting National IBD Guidelines
  • Giving

Breadcrumb

  1. People
  2. Jennifer Chen, MD
Image of Jennifer Chen, MD
  • Send an Email

View UCSF Profile

Jennifer Chen, MD

Education
06/2016 - Fellowship in Gastroenterology and Hepatology, Massachusetts General Hospital
06/2012 - Residency in Internal Medicine, Brigham and Women's Hospital
MD, 06/2009 - Doctor of Medicine, Harvard Medical School
AB, 06/2003 - Government, Harvard College
Websites
  • Posts on X @JenniferChenMD
  • The website of the Jennifer Chen laboratory at UCSF
Publications
  1. Sharma S, Prathigudupu V, Cable C, Serrano LR, Nerella S, Chen A, Hassan G, Lakins J, Valenzuela CL, Tsukui T, Ramamoorthi R, Kim JJ, Willenbring H, Mattis AN, Volk RF, Zaro BW, Coon JJ, Beresis R, DeGrado WF, Weaver VM, Christenson SA, Jo H, Chen JY. Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation. Science translational medicine 2025. PMID: 40864684


  2. Beresis R, Prathigudupu V, Cable C, Yu A, Adler M, Ramamoorthi R, Yeon SK, Gordan JD, Sharma S, DeGrado WF, Zaro B, Chen JY, Jo H. Exploration of a Class of Aryl Imidazolyl Ureas As Potent Acid Ceramidase Inhibitors for the Treatment of Fibrotic Diseases. ACS omega 2025. PMID: 40821548


  3. Kim RG, Patel S, Shui AM, Magee C, Chen JY, Tana M, Khalili M. Clinical Outcomes Following a Patient-Centered Educational Intervention on Steatotic Liver Disease: A Comparison of Patients With and Without Diabetes. Gastro Hep Advances 2025. PMID: 40786970


  4. Patel S, Partida D, Magee C, Garza Romero FE, Chen JY, Tana M, Khalili M. Steatotic Liver Disease Education Enhances Knowledge and Confidence to Adhere to Provider Recommendations in Diverse and Vulnerable Populations. Gastro Hep Advances 2024. PMID: 39931048


  5. Satre DD, Dasarathy D, Batki SL, Ostacher MJ, Snyder HR, Hua W, Parekh P, Shui AM, Cheung R, Monto A, Wong RJ, Chen JY, Liao M, Tana M, Chen PH, Haight CG, Fakadej T, Khalili M. Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease. Alimentary pharmacology & therapeutics 2024. PMID: 39523996


  6. Sun C, Zhou C, Daneshvar K, Ben Saad A, Kratkiewicz AJ, Toles BJ, Arghiani N, Hess A, Chen JY, Pondick JV, York SR, Li W, Moran SP, Gentile SD, Rahman RU, Li Z, Zhou P, Sparks RP, Habboub T, Kim BM, Choi MY, Affo S, Schwabe RF, Popov YV, Mullen AC. Conserved long noncoding RNA TILAM promotes liver fibrosis through interaction with PML in HSCs. Hepatology (Baltimore, Md.) 2024. PMID: 38563629


  7. Kim RG, Patel S, Satre DD, Shumway M, Chen JY, Magee C, Wong RJ, Monto A, Cheung R, Khalili M. Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease. Digestive diseases and sciences 2024. PMID: 38217682


  8. Yu A, Cable C, Sharma S, Shihan MH, Mattis AN, Mileva I, Hannun YA, Duwaerts CC, Chen JY. Targeting acid ceramidase ameliorates fibrosis in mouse models of non-alcoholic steatohepatitis. Frontiers in medicine 2022. PMID: 36275798


  9. Zhang P, Li X, Chen JY, Abate AR. Controlled fabrication of functional liver spheroids with microfluidic flow cytometric printing. Biofabrication 2022. PMID: 35917810


  10. Li W, Chen JY, Sun C, Sparks RP, Pantano L, Rahman RU, Moran SP, Pondick JV, Kirchner R, Wrobel D, Bieler M, Sauer A, Ho Sui SJ, Doerner JF, Rippmann JF, Mullen AC. Nanchangmycin regulates FYN, PTK2, and MAPK1/3 to control the fibrotic activity of human hepatic stellate cells. eLife 2022. PMID: 35617485


  11. Alsamman S, Christenson SA, Yu A, Ayad NME, Mooring MS, Segal JM, Hu JK, Schaub JR, Ho SS, Rao V, Marlow MM, Turner SM, Sedki M, Pantano L, Ghoshal S, Ferreira DDS, Ma HY, Duwaerts CC, Espanol-Suner R, Wei L, Newcomb B, Mileva I, Canals D, Hannun YA, Chung RT, Mattis AN, Fuchs BC, Tager AM, Yimlamai D, Weaver VM, Mullen AC, Sheppard D, Chen JY. Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice. Science translational medicine 2020. PMID: 32817366


  12. Chen JY, Ren Y, Yan P, Belina ME, Chung RT, Butt AA. Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES. Journal of viral hepatitis 2018. PMID: 29478294


  13. Caniglia EC, Zash R, Jacobson DL, Diseko M, Mayondi G, Lockman S, Chen JY, Mmalane M, Makhema J, Hernán MA, Shapiro RL. Emulating a target trial of antiretroviral therapy regimens started before conception and risk of adverse birth outcomes. AIDS (London, England) 2018. PMID: 29112066


  14. Chen JY, Newcomb B, Zhou C, Pondick JV, Ghoshal S, York SR, Motola DL, Coant N, Yi JK, Mao C, Tanabe KK, Bronova I, Berdyshev EV, Fuchs BC, Hannun Y, Chung RT, Mullen AC. Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells. Scientific Reports 2017. PMID: 28322247


  15. Zash R, Souda S, Chen JY, Binda K, Dryden-Peterson S, Lockman S, Mmalane M, Makhema J, Essex M, Shapiro R. Reassuring Birth Outcomes With Tenofovir/Emtricitabine/Efavirenz Used for Prevention of Mother-to-Child Transmission of HIV in Botswana. Journal of acquired immune deficiency syndromes (1999) 2016. PMID: 26379069


  16. Zhou C, York SR, Chen JY, Pondick JV, Motola DL, Chung RT, Mullen AC. Long noncoding RNAs expressed in human hepatic stellate cells form networks with extracellular matrix proteins. Genome medicine 2016. PMID: 27007663


  17. Dryden-Peterson S, Lockman S, Zash R, Lei Q, Chen JY, Souda S, Petlo C, Dintwa E, Lebelonyane R, Mmalane M, Shapiro RL. Initial programmatic implementation of WHO option B in Botswana associated with increased projected MTCT. Journal of acquired immune deficiency syndromes (1999) 2015. PMID: 25501611


  18. Kelly P, Saloojee H, Chen JY, Chung RT. Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects. Journal of acquired immune deficiency syndromes (1999) 2014. PMID: 25117963


  19. Chen JY, Feeney ER, Chung RT. HCV and HIV co-infection: mechanisms and management. Nature reviews. Gastroenterology & hepatology 2014. PMID: 24535328


  20. Chen JY, Chung RT. Future classes of hepatitis C virus therapeutic agents. Infectious disease clinics of North America 2012. PMID: 23083826


  21. Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S, Powis K, Dryden-Peterson S, Creek T, Jimbo W, Madidimalo T, Makhema J, Essex M, Shapiro RL. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. The Journal of infectious diseases 2012. PMID: 23066160


  22. Chung RT, Umbleja T, Chen JY, Andersen JW, Butt AA, Sherman KE. Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients. HIV clinical trials 2012. PMID: 22510354


  23. Matthews LT, Ribaudo HJ, Parekh NK, Chen JY, Binda K, Ogwu A, Makhema J, Souda S, Lockman S, Essex M, Shapiro RL. Birth weight for gestational age norms for a large cohort of infants born to HIV-negative women in Botswana compared with norms for U.S.-born black infants. BMC pediatrics 2011. PMID: 22176889


  24. Zhang Y, Lu L, Li HQ, Liu W, Tang ZR, Fang H, Chen JY, Ma Y, Zhao Y, Chen RY, Zhang FJ. Engaging HIV-infected patients in antiretroviral therapy services: CD4 cell count testing after HIV diagnosis from 2005 to 2009 in Yunnan and Guangxi, China. Chinese medical journal 2011. PMID: 21740803


  25. Chen JY, Chung RT. Can we use the "C" word with confidence? Cure for chronic hepatitis C. Gastroenterology 2011. PMID: 21256845


  26. Chen JY, Ogwu AC, Svab P, Lockman S, Moffat HJ, Gaolathe T, Moilwa S, Størdal K, Dryden-Peterson S, Moffat C, Makhema J, Essex M, Shapiro RL. Antiretroviral treatment initiation among HIV-infected pregnant women with low CD4(+) cell counts in Gaborone, Botswana. Journal of acquired immune deficiency syndromes (1999) 2010. PMID: 19864957


  27. Belkora JK, Loth MK, Chen DF, Chen JY, Volz S, Esserman LJ. Monitoring the implementation of Consultation Planning, Recording, and Summarizing in a breast care center. Patient education and counseling 2008. PMID: 18755564


UCSF Sublogo

 
© 2025 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Medicine                                                                  Accessibility  Privacy Policy  Terms of Use  A-Z Website List